Skip to content

Validation of Stenosis Assessment by Coronary Artery Computed Tomography Against Invasive Measurements of Fractional Flow Reserve in Patients With Significant Coronary Artery Stenoses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00817102
Enrollment
25
Registered
2009-01-06
Start date
2008-11-30
Completion date
2013-04-30
Last updated
2014-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Stenosis

Keywords

coronary artery stenoses

Brief summary

This study will evaluate the effectiveness of CorCTA by comparing the results of the test with another imaging method called Fractional Flow Reserve (FFR), which is done as a part of the cardiac catheterization.

Detailed description

Invasive X-ray coronary angiography remains the reference standard for the evaluation of coronary artery stenoses. Recently, coronary artery computed tomography angiography (CorCTA) has been introduced as a non-invasive method for the evaluation of coronary artery stenoses and has been shown to be highly accurate in stenosis detection when compared to invasive X-ray angiography. While invasive X-ray angiography and CorCTA evaluate morphological features of coronary arterial plaques, fractional flow reserve is an invasive measure of the hemodynamic significance of a stenosis obtained in the catheterization laboratory by measuring changes in intracoronary arterial pressure before and after maximal vasodilation induced by intracoronary adenosine. An FFR value less than 0.75 has been shown to predict ischemia in vascular beds distal to the stenosis by radionuclide perfusion modalities and has been shown to be associated with worse outcomes. Therefore, FFR is considered to be an invasive hemodynamic reference standard for the evaluation of the hemodynamic significance of coronary arterial stenoses. While intravascular ultrasound (IVUS) can provide additional morphological information in intermediate stenoses, it can not provide further functional information and cannot be used in more significant stenoses as the IVUS probe cannot be advanced through stenotic lesions. We are currently conducting investigation in the validation of CorCTA against FFR in intermediate coronary artery stenoses (40-70%) (see below under Preliminary Data). However, CorCTA has not been validated against invasive hemodynamic measurements of fractional flow reserve in patients with stenoses \>70% by invasive X-ray angiography. We hypothesize that CorCTA-derived measurements are accurate in the diagnosis of hemodynamically significant coronary artery stenoses, using FFR as the reference standard in patients with coronary artery stenoses\>70%.

Interventions

PROCEDUREFFR, IVUS, VH, or combination of the three

Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Virtual Histology (VH) or some combination of these three procedures will be completed during the cardiac catheterization procedure.

Sponsors

Piedmont Healthcare
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age 21-85 * Presence of at least one obstructive coronary artery stenosis as defined by: * Previous catheterization or CT angiogram with any lesion 70% or greater * Previous positive functional stress test (this does not include CTA alone) * Ability and Willingness to provide informed consent * Ability and Willingness to perform required follow up procedures

Exclusion criteria

* History of coronary artery bypass graft surgery * Previously revascularized lesion * Creatinine\>1.6 mg/dL or GFR\<30 pre-procedure per institutional standards * Known Pregnancy * Inability to perform CTA * Arrhythmia precluding diagnostic CT examination * Contrast agent allergy that cannot be adequately premedicated * Severe PVD precluding cardiac catheterization * Patient not a candidate for IVUS and FFR * Inability or unwillingness to provide informed consent * Inability or unwillingness to perform required follow up procedures

Design outcomes

Primary

MeasureTime frame
The CT-derived endpoints: Study lesion %DS predicting FFR<0.75; %AS predicting FFR<0.75; MLD predicting FFR<0.75; Study lesion MLA predicting FFR<0.75; IVUS-derived endpoints: Study lesion MLD predicting FFR<0.75; MLA predicting FFR<0.75Upon completion of tests

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026